Cargando…
Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study
Autores principales: | Kayser, Sabine, Rahmé, Ramy, Martínez-Cuadrón, David, Ghiaur, Gabriel, Thomas, Xavier, Sobas, Marta, Guerci-Bresler, Agnes, Garrido, Ana, Pigneux, Arnaud, Gil, Cristina, Raffoux, Emmanuel, Tormo, Mar, Vey, Norbert, de la Serna, Javier, Salamero, Olga, Lengfelder, Eva, Levis, Mark J., Fenaux, Pierre, Sanz, Miguel A., Platzbecker, Uwe, Schlenk, Richard F., Adès, Lionel, Montesinos, Pau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632664/ https://www.ncbi.nlm.nih.gov/pubmed/34785795 http://dx.doi.org/10.1038/s41375-021-01358-3 |
Ejemplares similares
-
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study
por: Kayser, Sabine, et al.
Publicado: (2020) -
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
por: Adès, Lionel, et al.
Publicado: (2018) -
Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
por: Ghiaur, Alexandra, et al.
Publicado: (2023) -
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study
por: Kayser, Sabine, et al.
Publicado: (2021) -
Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells
por: Huynh, Thomas T., et al.
Publicado: (2019)